University of California, Irvine scientists who study how circadian rhythms—our own body clocks—control liver function have discovered that cancerous lung tumors can hijack this process and profoundly alter metabolism.
May 5, 2016
0
38
Scientists believe that "conserved" genes—those found in life forms that range from bacteria to plants, insects and humans—perform vital biological functions across species. And limited research on one of those genes, ...
Mar 10, 2016
0
73
The use of certain traditional chemotherapy drugs may expand the number of tumors that respond to one of today's most promising cancer therapies - immune checkpoint blockade. Researchers from the Massachusetts General Hospital ...
Feb 16, 2016
0
2
A newly NIH funded clinical trial (NCT02528942) by University of Colorado Cancer Center investigators and collaborators at Beaumont Health in Michigan and the University of Texas Medical Branch is evaluating a new method ...
Jan 6, 2016
0
0
Pre-existing inflammation in the lungs may increase the risk that cancers beginning elsewhere will spread to that organ, according to new research from Weill Cornell Medicine.
Dec 15, 2015
0
66
Stunned scientists described on Wednesday the first known case of a man infected with tumors by a common parasitic tapeworm, raising concern about more such infections that may go undetected.
Nov 4, 2015
0
83
Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.
Sep 30, 2015
0
8
If cancer patients are to receive optimal treatment, clinicians must have an accurate histologic classification of the tumor and know its genetic characteristics, said William D. Travis, M.D., attending thoracic pathologist, ...
Sep 8, 2015
0
21
Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, researchers from Weill Cornell Medical College have found.
Jul 16, 2015
0
40
New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.
Apr 20, 2015
0
4
